Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management

 Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management

Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management

Shots:

  • The companies collaborated to develop & commercialize integrated diabetes solutions combining Abbott’s FreeStyle Libre System with the Tandem’s t:slim X2 insulin pump expanding choice for the patients to manage diabetes
  • The focus of the agreement is to combine Abbott’s and Tandem’s leadership and expertise to provide people with new ways to manage their diabetes, integrating easily into their daily lives
  • Abbott’s FreeStyle Libre is a sensor-based glucose monitoring system, reads glucose levels via sensor that can be worn on the back of the upper arm eliminating the need for fingerstick. The Tandem’s t:slim X2 is an alternate controller enabled (ACE) infusion pumps and is the first system to approved as compatible with interoperable continuous glucose monitoring (iCGM) devices

Click here to­ read full press release/ article | Ref: Abbott | Image: ESD Global

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post